HEKETISS SA

Off-the-shelf stem cell therapy for wound and skin repair

Turning fat into life.

HekeTiss is a pioneering cell therapy biotech focused on developing patent-backed, off-the-shelf allogeneic stem cell therapies to accelerate the regeneration of damaged skin and restore skin health. Founded in 2021 as a spin-off from UNIGE and HUG, HekeTiss developed TrophiPatch, a first-of-its-kind skin patch derived from functionally enhanced donor fat stem cells. TrophiPatch is designed to regenerate blood vessels in chronic wounds, an essential factor for superior healing. Convenient and easy to apply, the patch naturally resorbs, providing a unique and effective solution for wounds that resist conventional treatments.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

07.05.2025

Lightium wins the 32nd Prix Strategis (startupticker.ch)

02.04.2025

Prix Strategis 2025 Finalists unveiled (startupticker.ch)

05.11.2024

Bio Europe in Stockholm hosts 33 Swiss companies (startupticker.ch)

25.06.2024

CERN and UNIGE Spinoffs awarded FIF Funding (startupticker.ch)

Milestone

23.08.2024

Awarded with the Innosuisse Certificate "ready for sustainable growth"

Milestone

09.07.2024

Secured first investors

Milestone

01.04.2024

Completed tech transfer in GMP labs, now ready for clinical-grade production of TrophiPatch.

Milestone

21.03.2023

Efficacy successfully demonstrated in animal proof-of-concept studies.

Milestone

27.07.2022

Patent PCT/EP2020/076083 entered national phases in the EU and US.

No Jobs

Videos

Office de Promotion des Industries et des Technologies - Rencontre avec Nicolò Brembilla et Olivier Preynat-Seauve co-fondateurs d'HekeTiss

TOP 100 Swiss Startup Award

The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.

Website

UNIGE Spin-off

Website

HEKETISS SA

Off-the-shelf stem cell therapy for wound and skin repair

Headquarter:
Plan-les-Ouates

Foundation Date:
November 2021

Technology:

  • Biotech

Sectors:

  • Biotech
  • Organ and Tissues

Support received

  • Support TOP 100